QX-006N

N/A

Report date: 2022/05/07 11:03:23

Base Information

Drug NameQX-006N
Drug Alias NameQX-006NQX006N
ClassificationBiologics
Mechanisms of ActionInterferon alpha/beta receptor inhibitors
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQyuns Therapeutics Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesQyuns Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A